You are here : Home > Services > Supply of Intermediates
Pharmaceutical Intermediates Supply

The CARBOGEN AMCIS Ltd. Manchester facility focuses on process optimization and the synthesis of nonGMP pharmaceutical intermediates.  The large-scale production capacities (up to 4’500 L, with a temperature range from -80°C to +250 °C) allow the efficient production of early-phase APIs and large-scale intermediates under nonGMP conditions that can be further processed at the CARBOGEN AMCIS Swiss’ facilities. The extensive distillation capabilities offer a significant expansion to the purification capabilities of CARBOGEN AMCIS AG.

News
11 October 2017
CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland

21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

11 August 2016
Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS


Events
Bio-Europe

Chemtogether ETHZ